Clinical Trial Update: Lapatinib and Circulating Tumor Cells in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lapatinib in metastatic breast cancer has completed, with circulating tumor cells studied as a biomarker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: University Hospital of Crete | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED